NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARMERS & MERCHANTS INVESTMENTS INC | 113 | $65 | 0.00% |
| STATE STREET CORP | 725,937 | $417,559 | 0.00% |
| SG Americas Securities, LLC | 107,236 | $62 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 66,650 | $39 | 0.00% |
| Graham Capital Management, L.P. | 24,095 | $13,859 | 0.00% |
| HARBOUR INVESTMENTS, INC. | 155 | $89 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 1,293 | $1 | 0.00% |
| AMERIPRISE FINANCIAL INC | 490,400 | $282,078 | 0.00% |
| MACQUARIE GROUP LTD | 256,385 | $147,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 384,555 | $221,196 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 14,585 | $8,389 | 0.00% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q2 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.